Cargando…

Categorizing IQOS-Related Twitter Discussions

(1) Background: The heated tobacco product IQOS, by Philip Morris International, is now available in over 55 countries, including the United States. Social media sites such as Twitter are often used to promote or discuss tobacco products, though prior research has not examined how IQOS is presented...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Joshua O., Vassey, Julia, Chen-Sankey, Julia C., Allem, Jon-Patrick, Cruz, Tess Boley, Unger, Jennifer B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124933/
https://www.ncbi.nlm.nih.gov/pubmed/33946546
http://dx.doi.org/10.3390/ijerph18094836
_version_ 1783693353070624768
author Barker, Joshua O.
Vassey, Julia
Chen-Sankey, Julia C.
Allem, Jon-Patrick
Cruz, Tess Boley
Unger, Jennifer B.
author_facet Barker, Joshua O.
Vassey, Julia
Chen-Sankey, Julia C.
Allem, Jon-Patrick
Cruz, Tess Boley
Unger, Jennifer B.
author_sort Barker, Joshua O.
collection PubMed
description (1) Background: The heated tobacco product IQOS, by Philip Morris International, is now available in over 55 countries, including the United States. Social media sites such as Twitter are often used to promote or discuss tobacco products, though prior research has not examined how IQOS is presented on Twitter. (2) Methods: This study collected and categorized Twitter conversations involving IQOS. A manual content analysis was performed on N = 3916 English tweets related to IQOS published internationally between 1 January 2020 and 30 June 2020. (3) Results: Most tweets were either online marketing for IQOS (32.3%) or personal testimonials related to IQOS use (34.2%). Personal testimonial tweets made harm reduction claims about IQOS either as an avenue to quit smoking/tobacco use (3.4%), or in comparison to combustible cigarettes (2.0%). Tobacco policy-related tweets were detected (13.9%), split between discussions of United States (4.9%) and international (4.4%) policies. News media tweets (14.2%) were also detected. (4) Conclusions: Our study suggests IQOS may be understood as a less harmful alternative to vaping and combustible cigarettes. Discussions also suggest IQOS is likely to be used to avoid clean air policies or used in areas in which smoking is restricted.
format Online
Article
Text
id pubmed-8124933
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81249332021-05-17 Categorizing IQOS-Related Twitter Discussions Barker, Joshua O. Vassey, Julia Chen-Sankey, Julia C. Allem, Jon-Patrick Cruz, Tess Boley Unger, Jennifer B. Int J Environ Res Public Health Article (1) Background: The heated tobacco product IQOS, by Philip Morris International, is now available in over 55 countries, including the United States. Social media sites such as Twitter are often used to promote or discuss tobacco products, though prior research has not examined how IQOS is presented on Twitter. (2) Methods: This study collected and categorized Twitter conversations involving IQOS. A manual content analysis was performed on N = 3916 English tweets related to IQOS published internationally between 1 January 2020 and 30 June 2020. (3) Results: Most tweets were either online marketing for IQOS (32.3%) or personal testimonials related to IQOS use (34.2%). Personal testimonial tweets made harm reduction claims about IQOS either as an avenue to quit smoking/tobacco use (3.4%), or in comparison to combustible cigarettes (2.0%). Tobacco policy-related tweets were detected (13.9%), split between discussions of United States (4.9%) and international (4.4%) policies. News media tweets (14.2%) were also detected. (4) Conclusions: Our study suggests IQOS may be understood as a less harmful alternative to vaping and combustible cigarettes. Discussions also suggest IQOS is likely to be used to avoid clean air policies or used in areas in which smoking is restricted. MDPI 2021-04-30 /pmc/articles/PMC8124933/ /pubmed/33946546 http://dx.doi.org/10.3390/ijerph18094836 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Barker, Joshua O.
Vassey, Julia
Chen-Sankey, Julia C.
Allem, Jon-Patrick
Cruz, Tess Boley
Unger, Jennifer B.
Categorizing IQOS-Related Twitter Discussions
title Categorizing IQOS-Related Twitter Discussions
title_full Categorizing IQOS-Related Twitter Discussions
title_fullStr Categorizing IQOS-Related Twitter Discussions
title_full_unstemmed Categorizing IQOS-Related Twitter Discussions
title_short Categorizing IQOS-Related Twitter Discussions
title_sort categorizing iqos-related twitter discussions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124933/
https://www.ncbi.nlm.nih.gov/pubmed/33946546
http://dx.doi.org/10.3390/ijerph18094836
work_keys_str_mv AT barkerjoshuao categorizingiqosrelatedtwitterdiscussions
AT vasseyjulia categorizingiqosrelatedtwitterdiscussions
AT chensankeyjuliac categorizingiqosrelatedtwitterdiscussions
AT allemjonpatrick categorizingiqosrelatedtwitterdiscussions
AT cruztessboley categorizingiqosrelatedtwitterdiscussions
AT ungerjenniferb categorizingiqosrelatedtwitterdiscussions